Loading...
XTAE
NISA
Market cap28mUSD
Dec 04, Last price  
998.10ILS
1D
0.00%
1Q
-12.98%
Jan 2017
-74.32%
Name

Nissan Medical Industries Ltd

Chart & Performance

D1W1MN
XTAE:NISA chart
P/E
11.47
P/S
0.14
EPS
0.87
Div Yield, %
Shrs. gr., 5y
-15.13%
Rev. gr., 5y
1.87%
Revenues
664m
-9.52%
466,789,000512,208,000529,957,000509,478,000584,389,000658,386,000605,462,000721,481,000668,372,000684,647,000733,914,000664,079,000
Net income
8m
+39.95%
46,702,000603,00037,132,00017,909,00012,709,00025,102,00015,709,00056,846,00036,012,000-36,049,0005,649,0007,906,000
CFO
27m
-74.62%
72,612,00077,113,000120,183,00044,178,00052,352,00085,837,00055,764,000122,569,00017,978,00011,674,000105,715,00026,833,000
Dividend
Mar 01, 202244 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nissan Medical Industries Ltd, through its subsidiary, engages in the manufacturing and marketing of spunlace non-woven fabrics in the United States, Canada, Europe, and Israel. The company's products are used in reusable and consumable consumer products, medical products, automotive, infrastructure, hygienic, and other industries. It sells its products through its sales agents. Nissan Medical Industries Ltd was incorporated in 1984 and is based in Tel Aviv-Yafo, Israel.
URL
IPO date
Jan 01, 1993
Employees
386
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT